Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

This study has been terminated.
(Low accrual)
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00322855
First received: May 5, 2006
Last updated: July 10, 2015
Last verified: July 2015
  Purpose
To review the outcome of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005.

Condition
Sarcoma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Chart Review of Treatments Received by Patients Diagnosed With Soft Tissue Sarcoma

Resource links provided by NLM:


Further study details as provided by New Mexico Cancer Care Alliance:

Primary Outcome Measures:
  • To Review the Outcome of Patients With Soft Tissue Sarcoma Treated With Chemotherapy From 2004 and 2005 [ Time Frame: up to one year ] [ Designated as safety issue: No ]

Enrollment: 1
Study Start Date: August 2005
Study Completion Date: August 2007
Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
Chart Review
patients diagnosed with soft tissue sarcoma

Detailed Description:
Chart review of patients with soft tissue sarcoma treated with chemotherapy from 2004 and 2005 to determine outcome
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.
Criteria

Inclusion Criteria:

  • Patients diagnosed with soft tissue sarcoma treated with chemotherapy form 2004 and 2005.

Exclusion Criteria:

  • Not Specified
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00322855

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Aroop Mangalik, MD University of New Mexico
  More Information

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00322855     History of Changes
Other Study ID Numbers: INST 0517C 
Study First Received: May 5, 2006
Results First Received: June 16, 2015
Last Updated: July 10, 2015
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Sarcoma
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on September 27, 2016